[HTML][HTML] SARS-CoV-2 Omicron BA. 5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral …
A Aggarwal, A Akerman, V Milogiannakis, MR Silva… - …, 2022 - thelancet.com
Background Genetically distinct viral variants of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) have been recorded since January 2020. The introduction of global …
2 (SARS-CoV-2) have been recorded since January 2020. The introduction of global …
[HTML][HTML] Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia
…, G Walker, A Akerman, C Esneau, V Milogiannakis… - Nature …, 2022 - nature.com
Genetically distinct variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have emerged since the start of the COVID-19 pandemic. Over this period, we developed …
have emerged since the start of the COVID-19 pandemic. Over this period, we developed …
SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern
…, AO Stella, G Walker, A Akerman, V Milogiannakis… - medrxiv, 2021 - medrxiv.org
Genetically distinct viral variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have been recorded since January 2020. Over this time global vaccine programs …
have been recorded since January 2020. Over this time global vaccine programs …
[HTML][HTML] Emergence and antibody evasion of BQ, BA. 2.75 and SARS-CoV-2 recombinant sub-lineages in the face of maturing antibody breadth at the population level
A Akerman, V Milogiannakis, T Jean, C Esneau… - …, 2023 - thelancet.com
Background The Omicron era of the COVID-19 pandemic commenced at the beginning of
2022 and whilst it started with primarily BA.1, it was latter dominated by BA.2 and the related …
2022 and whilst it started with primarily BA.1, it was latter dominated by BA.2 and the related …
Multiple COVID-19 vaccine doses in CLL and MBL improve immune responses with progressive and high seroconversion
…, A Aggarwal, V Milogiannakis… - Blood, The Journal …, 2022 - ashpublications.org
Patients with chronic lymphocytic leukemia (CLL) or monoclonal B-lymphocytosis (MBL) have
impaired response to COVID-19 vaccination. A total of 258 patients (215 with CLL and 43 …
impaired response to COVID-19 vaccination. A total of 258 patients (215 with CLL and 43 …
COVID‐19 vaccine failure in chronic lymphocytic leukaemia and monoclonal B‐lymphocytosis; humoural and cellular immunity
…, N Van Bilsen, V Milogiannakis… - British Journal of …, 2022 - Wiley Online Library
Chronic lymphocytic leukaemia (CLL) is associated with immunocompromise and high risk
of severe COVID‐19 disease and mortality. Monoclonal B‐cell lymphocytosis (MBL) patients …
of severe COVID‐19 disease and mortality. Monoclonal B‐cell lymphocytosis (MBL) patients …
[HTML][HTML] Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2
…, A Aggarwal, AO Stella, A Akerman, V Milogiannakis… - Antiviral Research, 2023 - Elsevier
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a respiratory virus that
causes COVID-19 disease, with an estimated global mortality of approximately 2%. While …
causes COVID-19 disease, with an estimated global mortality of approximately 2%. While …
[HTML][HTML] Enhanced stability of the SARS CoV-2 spike glycoprotein following modification of an alanine cavity in the protein core
…, T Zakir, RJ Center, A Akerman, V Milogiannakis… - PLoS …, 2023 - journals.plos.org
The spike (S) glycoprotein of SARS CoV-2 is the target of neutralizing antibodies (NAbs)
that are crucial for vaccine effectiveness. The S1 subunit binds ACE2 while the S2 subunit …
that are crucial for vaccine effectiveness. The S1 subunit binds ACE2 while the S2 subunit …
[HTML][HTML] Humoral and cellular immunity to SARS-CoV-2 Ancestral and Omicron BA. 5 variants following vaccination in myelofibrosis patients
…, A Akerman, A Aggarwal, V Milogiannakis… - Blood Cancer …, 2023 - nature.com
Myelofibrosis (MF) is a clonal myeloproliferative neoplasm associated with inflammatory
manifestations including fibrosis and constitutional symptoms. The standard treatment for …
manifestations including fibrosis and constitutional symptoms. The standard treatment for …
[HTML][HTML] High titre neutralizing antibodies in response to SARS–CoV–2 infection require RBD–specific CD4 T cells that include proliferative memory cells
…, A Aggarwal, A Akerman, V Milogiannakis… - Frontiers in …, 2022 - frontiersin.org
Background Long-term immunity to SARS-CoV-2 infection, including neutralizing antibodies
and T cell-mediated immunity, is required in a very large majority of the population in order …
and T cell-mediated immunity, is required in a very large majority of the population in order …